Premas Biotech Revenue and Competitors
Estimated Revenue & Valuation
- Premas Biotech's estimated annual revenue is currently $16.6M per year.
- Premas Biotech's estimated revenue per employee is $77,500
Employee Data
- Premas Biotech has 214 Employees.
- Premas Biotech grew their employee count by 4% last year.
Premas Biotech's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Manufacturing officer | Reveal Email/Phone |
2 | Head - Global Business Development | Reveal Email/Phone |
3 | Head HR | Reveal Email/Phone |
4 | Manufacturing Officer | Reveal Email/Phone |
5 | Senior Manufacturing Officer (Downstream Processing) | Reveal Email/Phone |
6 | Cofounder & Managing Director | Reveal Email/Phone |
7 | Information Technology Manager | Reveal Email/Phone |
8 | Assistant Manager | Reveal Email/Phone |
9 | Assistant Manager | Reveal Email/Phone |
10 | Manager SCM | Reveal Email/Phone |
Premas Biotech Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12M | 155 | -4% | N/A | N/A |
#2 | $17.3M | 223 | 18% | N/A | N/A |
#3 | $11.1M | 143 | 34% | N/A | N/A |
#4 | $8.2M | 106 | 8% | N/A | N/A |
#5 | $9.5M | 123 | 10% | N/A | N/A |
#6 | $21.2M | 273 | 8% | N/A | N/A |
#7 | $12M | 155 | 8% | N/A | N/A |
#8 | $18.9M | 244 | 5% | N/A | N/A |
#9 | $12.5M | 161 | 9% | N/A | N/A |
#10 | $20.5M | 264 | 8% | N/A | N/A |
What Is Premas Biotech?
Premas Biotech is an established technology-driven protein research organization, providing high-quality customized services for Gene to IND for protein bio-therapeutics. Premas works with top global pharma/biotech companies and has successfully delivered 5 therapeutics into clinics. In that path, we have developed more than 650 difficult to express proteins. We are focused on technologies integrated with process development for solving critical bottlenecks in the therapeutic development process. Apart from our services, we wish to partner on the following below: a. Recombinant CRM197 platform for Polysaccharide vaccines. b. Novel Human Naïve Antibody Library: for generation of novel Mabs, scFvs, diabodies and bispecifics. Recently, Premas successfully entered the late-stage clinical trials with Oramed for the first ever human oral insulin pill. Premas Biotech is committed to offer valuable, high-tech and quality based solutions; and with our highly skilled team, technology and expertise, we have consistently and seamlessly provided high quality services to our clients.
keywords:N/A
N/A
Total Funding
214
Number of Employees
$16.6M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Premas Biotech News
GURUGRAM, India--(BUSINESS WIRE)--Mar 19, 2021-- Premas Biotech, a developer of novel biotherapeutic and vaccine candidates, announced today the development of an oral COVID-19 vaccine that has shown efficacy after a single dose, in conjunction with Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORM ...
Other Companies in Gurgaon
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 214 | 35% | N/A |
#2 | $38.2M | 215 | 5% | N/A |
#3 | $24.5M | 218 | 42% | N/A |
#4 | $16.8M | 218 | 24% | N/A |
#5 | $16.9M | 219 | -47% | $16M |